Jun Li

7158997, Jan 2, 2007

Oct 7, 2004

10/960741

Arnold N. Blinn - Bellevue WA, US
Jun Li - Seattle WA, US
Trevor Traina - Seattle WA, US

Microsoft Corporation - Redmond WA

G06F 17/30

7071041, 707 10, 707100

A business model is described in which one entity hosts, maintains, and provides a uniform interface for entering data into, a database of manufacturers product specification on behalf of a plurality of manufacturers. The entity then serves as an application service provider (ASP) with respect to that database, by allowing the manufacturers to access their respective product specification data in the database for any of a variety of uses outside of the database in exchange for some form of remuneration from those manufacturers.

7321901, Jan 22, 2008

Sep 29, 2000

09/676365

Arnold N. Blinn - Bellevue WA, US
Jun Li - Seattle WA, US
Trevor Traina - Seattle WA, US

Microsoft Corporation - Redmond WA

G06F 17/30

7071041, 707100, 707101

A business model is described in which one entity hosts, maintains, and provides a uniform interface for entering data into, a database of manufacturers product specification on behalf of a plurality of manufacturers. The entity then serves as an application service provider (ASP) with respect to that database, by allowing the manufacturers to access their respective product specification data in the database for any of a variety of uses outside of the database in exchange for some form of remuneration from those manufacturers.

8308699, Nov 13, 2012

Dec 7, 2009

12/632669

Zheng Zhang - Cambridge MA, US
Chad Huval - Somerville MA, US
William Shannan O'Shaughnessey - Boston MA, US
Michael Hencke - Cambridge MA, US
Trevor Squier - Peabody MA, US
Jun Li - Brookline MA, US
Michael Bouchard - Wyomissing PA, US
Christopher R. Loose - Cambridge MA, US

Semprus Biosciences Corp. - Cambridge MA

A61M 25/00
C08F 290/14
C08F 112/08
C08F 283/04
C08F 120/10
C08F 20/56
C08F 283/02
C08G 77/38

604265, 428413, 4284744, 428480, 442123, 5253291, 5253294, 5253303, 5253333, 5253337, 525418, 525419, 525453, 525462, 525474, 525 50, 525523, 525535, 5361231

Substrates, optionally coated with an undercoating, having grafted thereto one or more non-fouling materials are described herein. The non-fouling, polymeric material can be grafted to a variety of functionalized substrate materials, particularly polymeric substrates and/or polymeric undercoatings immobilized on a substrate. The compositions described herein are highly resistant protein absorption, particularly in complex media and retain a high degree of non-fouling activity over long periods of time. The compositions described herein may also demonstrate antimicrobial and/or anti-thrombogenic activity. The non-fouling material can be grafted to a functionalized substrate, or optionally from an undercoating on the substrate, preferably without significantly affecting the mechanical and/or physical properties of the substrate material.

8574660, Nov 5, 2013

Jun 9, 2011

13/156904

Douglas J. K. Weaver - Cambridge MA, US
Jun Li - Cambridge MA, US
Zheng Zhang - Cambridge MA, US
Abby N. Deleault - Cambridge MA, US
Eric W. Marchese - Cambridge MA, US
Phu C. Nguyen - Cambridge MA, US
Chad C. Huval - Cambridge MA, US
Michael A. Bouchard - Cambridge MA, US
Arthur J. Coury - Cambridge MA, US
Christopher R. Loose - Cambridge MA, US

Semprus Biosciences Corporation - Boston MA

A61L 33/00

427 225, 424423, 530423, 530326, 530327

Processes are described herein for preparing medical devices and other articles having a low-fouling surface on a substrate comprising a polymeric surface. The polymeric surface material may possess a range of polymeric backbones and substituents while providing the articles with a highly efficient, biocompatible, and non-fouling surface. The processes involve treating the substrate to reduce the concentration of chemical species on the surface of or in the substrate without altering the bulk physical properties of the device or article, and thereafter forming a grafted polymer layer on the treated substrate surface.

20100152708, Jun 17, 2010

Dec 7, 2009

12/632686

Jun Li - Brookline MA, US
Trevor Squier - Peabody MA, US
Zheng Zhang - Cambridge MA, US
Chad Huval - Somerville MA, US
William Shannan O'Shaughnessy - Boston MA, US
Michael Hencke - Cambridge MA, US
Michael Bouchard - Wyomissing PA, US
Christopher R. Loose - Cambridge MA, US

A61L 29/14
C08F 290/14
B32B 5/02
B32B 15/08
B32B 27/04
B32B 27/36
B32B 9/04
B32B 27/38
C08F 112/08
C08F 283/04
C08F 283/06
C08F 283/12
C08F 220/56
C08F 210/00
C07H 1/00
C07H 23/00
C08J 3/28
B05D 3/06

604523, 525 50, 442123, 428446, 428457, 428461, 428458, 428412, 428447, 428413, 428418, 5253333, 525453, 5253303, 5253294, 525418, 525474, 525477, 525523, 5253262, 5253337, 5361231, 536121, 522149, 427553

Substrates, optionally coated with an undercoating layer, having grafted there from one or more non-fouling materials are described herein. The non-fouling, polymeric material can be grafted from a variety of substrate materials, particularly polymeric substrates and/or polymeric undercoating layers. The graft-from techniques described herein can result in higher surface densities of the non-fouling material relative to graft-to formulations. Graft-from methods can be used to produce covalently tethered polymers. The compositions described herein are highly resistant protein absorption, particularly in complex media and retain a high degree of non-fouling activity over long periods of time. The compositions described herein may also demonstrate antimicrobial and/or anti-thrombogenic activity. The non-fouling material can be grafted from the substrate, or optionally from an undercoating layer on the substrate, preferably without significantly affecting the mechanical and/or physical properties of the substrate material.

20110305872, Dec 15, 2011

Jun 9, 2011

13/156677

Jun Li - Cambridge MA, US
Zheng Zhang - Cambridge MA, US
Chad C. Huval - Cambridge MA, US
Michael A. Bouchard - Cambridge MA, US
Arthur J. Coury - Cambridge MA, US
Christopher R. Loose - Cambridge MA, US

B32B 3/00
D03D 15/00
D04H 13/00
B05D 3/10

428141, 427340, 428336, 442181, 442327

A method for preparing and resulting articles of manufacture comprising a substrate having a surface, a bulk beneath the surface, and a grafted polymer layer on the substrate surface, the substrate surface and the grafted polymer layer, in combination, constituting a modified surface having a fibrinogen adsorption of less than about 125 ng/cmin a fibrinogen binding assay in which the modified surface is incubated for 60 minutes at 37 C. in 70 μg/mL fibrinogen derived from human plasma containing 1.4 μg/mL I-125 radiolabeled fibrinogen.

20110305898, Dec 15, 2011

Jun 9, 2011

13/156708

Zheng Zhang - Cambridge MA, US
Jun Li - Cambridge MA, US
Chad C. Huval - Cambridge MA, US
Michael A. Bouchard - Cambridge MA, US
Arthur J. Coury - Cambridge MA, US
Christopher R. Loose - Cambridge MA, US

B32B 3/00
B32B 9/04
B32B 27/40
B32B 27/00
B32B 17/06
D04H 13/00
D03D 15/00
A61L 33/00
B32B 15/04

428336, 427 224, 4284111, 4284231, 428457, 428426, 442327, 442181, 428332, 428500

The present invention generally relates to articles of manufacture, such as medical devices, having a non-fouling surface comprising a grafted polymer material. The surface resists the adhesion of biological material.

20120178184, Jul 12, 2012

Mar 29, 2012

13/433444

Jianfei YANG - Lexington MA, US
Frank James KING - New Milford CT, US
Jun LI - Danbury CT, US
Zhen Hao QI - Sandy Hook CT, US
Ming XUE - Newtown CT, US

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. - Ridgefield CT

G01N 33/566
C07K 16/18
C07K 14/435

436501, 530350, 5303879

The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.